United States Healthcare Providers & Services

Enhabit Inc (EHAB)

Track

The most recent insider trading activity at Enhabit Inc. occurred on March 11, 2026, involving sales by the Chief Accounting Officer. Additional sales were recorded by the EVP of Home Health Operations on March 9 and 10, 2026. No insider transactions have been reported in the last three months.
Ticker: EHAB Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Enhabit Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 11 Mar 2026
Value US$2,981,430.30 | Price 417.87 | Shares 24,976 (+45.0%)
Proposed sale 11 Mar 2026
Value US$2,085,242.74 | Price 478.76 | Shares 51,972
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-11 2026-03-11 S Sale
1.9
McQuiddy Collin

Chief Accounting Officer

Officer
24,976 +45.0%
417.87
US$2,981,430 		24,976 +45.0% 417.87 US$2,981,430
2026-03-11 2026-03-11 PrS Proposed sale
1.9
McQuiddy Collin

Officer

Officer
51,972
478.76
US$2,085,243 		51,972 478.76 US$2,085,243
2026-03-11 2026-03-10 S Sale
Jolley Julie Diane

EVP of Home Health Operations

Officer
58,696 +22.2%
132.60
US$3,955,326 		58,696 +22.2% 132.60 US$3,955,326
2026-03-10 2026-03-10 PrS Proposed sale
Jolley Julie Diane

Officer

Officer
5,586
13.64
US$76,193 		5,586 13.64 US$76,193
2026-03-11 2026-03-09 S Sale
Jolley Julie Diane

EVP of Home Health Operations

Officer
2,793 -2.0%
13.63
US$38,069 		2,793 -2.0% 13.63 US$38,069
2025-08-11 2025-08-08 B Purchase
2.7
Solomon Ryan

Chief Financial Officer

Officer
10,000 +5.5%
7.64
US$76,400 		10,000 +5.5% 7.64 US$76,400
2025-03-10 2025-03-10 S Sale
1.9
McQuiddy Collin

Chief Accounting Officer

Officer
1,096 -100.0%
8.58
US$9,404 		1,096 -100.0% 8.58 US$9,404
2024-12-12 2024-12-12 B Purchase
3.5
Bolton Jeffrey
Non-Executive Director
4,000 +4.2%
8.69
US$34,760 		4,000 +4.2% 8.69 US$34,760
2024-12-11 2024-12-10 B Purchase
0.9
MCGUIGAN STUART M
Non-Executive Director
15,000 +47.2%
8.81
US$132,150 		15,000 +47.2% 8.81 US$132,150
2024-11-12 2024-11-12 B Purchase
3.5
Bolton Jeffrey
Non-Executive Director
3,000 +3.3%
7.60
US$22,800 		3,000 +3.3% 7.60 US$22,800
2024-11-12 2024-11-08 B Purchase
3.5
Bolton Jeffrey
Non-Executive Director
6,351 +7.5%
7.77
US$49,347 		6,351 +7.5% 7.77 US$49,347
2024-11-12 2024-11-08 B Purchase
3.5
Bolton Jeffrey
Non-Executive Director
649 +0.8%
7.75
US$5,030 		649 +0.8% 7.75 US$5,030
2024-08-23 2024-08-22 B Purchase
3.5
Bolton Jeffrey
Non-Executive Director
5,000 +6.8%
8.01
US$40,050 		5,000 +6.8% 8.01 US$40,050
2024-08-12 2024-08-09 B Purchase
3.5
Bolton Jeffrey
Non-Executive Director
5,000 +7.3%
8.29
US$41,450 		5,000 +7.3% 8.29 US$41,450
2024-08-12 2024-08-08 B Purchase
3.5
Bolton Jeffrey
Non-Executive Director
2,000 +3.0%
8.60
US$17,200 		2,000 +3.0% 8.60 US$17,200
2024-05-17 2024-05-17 B Purchase
3.5
Bolton Jeffrey
Non-Executive Director
10,000 +23.6%
8.33
US$83,300 		10,000 +23.6% 8.33 US$83,300
2024-05-15 2024-05-14 B Purchase
2.6
Hoeflinger Erin
Non-Executive Director
2,000 +7.0%
9.00
US$18,000 		2,000 +7.0% 9.00 US$18,000
2024-05-10 2024-05-10 B Purchase
3.5
Bolton Jeffrey
Non-Executive Director
10,000 +31.0%
8.24
US$82,400 		10,000 +31.0% 8.24 US$82,400
2024-05-10 2024-05-10 B Purchase
3.5
Bolton Jeffrey
Non-Executive Director
10,000 +31.0%
8.24
US$82,400 		10,000 +31.0% 8.24 US$82,400
2024-03-05 2024-03-01 S Sale
1.7
Langham Ronald Leroy JR

EVP Clinical Excel. & Strategy

Officer
634 -1.1%
8.81
US$5,586 		634 -1.1% 8.81 US$5,586
2023-05-31 2023-05-26 B Purchase
3.5
Bolton Jeffrey
Non-Executive Director
2,000 +11.4%
11.61
US$23,220 		2,000 +11.4% 11.61 US$23,220
2023-05-23 2023-05-22 B Purchase
3.2
SHAW L EDWARD JR
Non-Executive Director
10,000 +34.5%
11.98
US$119,800 		10,000 +34.5% 11.98 US$119,800
2023-05-22 2023-05-18 B Purchase
2.6
Hoeflinger Erin
Non-Executive Director
2,100 +15.4%
11.82
US$24,822 		2,100 +15.4% 11.82 US$24,822
2023-05-22 2023-05-18 B Purchase
1.7
Langham Ronald Leroy JR

EVP Clinical Excel. & Strategy

Officer
10,000 +29.1%
11.99
US$119,900 		10,000 +29.1% 11.99 US$119,900
2023-05-18 2023-05-17 B Purchase
3.5
Bolton Jeffrey
Non-Executive Director
2,000 +12.8%
11.80
US$23,600 		2,000 +12.8% 11.80 US$23,600
2022-11-22 2022-11-18 B Purchase
3.5
Bolton Jeffrey
Non-Executive Director
1,000 +6.9%
12.69
US$12,690 		1,000 +6.9% 12.69 US$12,690
2022-11-10 2022-11-09 B Purchase
3.5
Bolton Jeffrey
Non-Executive Director
2,000 +15.9%
12.75
US$25,500 		2,000 +15.9% 12.75 US$25,500
2022-11-10 2022-11-08 B Purchase
3.5
Bolton Jeffrey
Non-Executive Director
2,000 +18.9%
12.89
US$25,780 		2,000 +18.9% 12.89 US$25,780
2022-11-09 2022-11-08 B Purchase
3.4
HIGDON LEO I JR
Non-Executive Director
426 +5.7%
13.57
US$5,781 		426 +5.7% 13.57 US$5,781
2022-11-08 2022-11-07 B Purchase
3.4
Rush Gregory S
Non-Executive Director
8,300 +100.0%
12.69
US$105,327 		8,300 +100.0% 12.69 US$105,327
2022-11-08 2022-11-04 B Purchase
3.4
Rush Gregory S
Non-Executive Director
1,700 +25.8%
12.58
US$21,386 		1,700 +25.8% 12.58 US$21,386
2022-09-02 2022-08-31 B Purchase
0.7
Brown-Stevenson Tina L.
Non-Executive Director
1,550 +19.1%
15.99
US$24,784 		1,550 +19.1% 15.99 US$24,784
2022-08-22 2022-08-19 B Purchase
2.6
Hoeflinger Erin
Non-Executive Director
970 +7.7%
13.90
US$13,483 		970 +7.7% 13.90 US$13,483
2022-08-22 2022-08-18 B Purchase
2.6
Hoeflinger Erin
Non-Executive Director
6,030 +91.4%
13.62
US$82,129 		6,030 +91.4% 13.62 US$82,129
2022-08-19 2022-08-17 B Purchase
1.5
Marion Tanya Renee

Chief Human Resources Officer

Officer
1,712 +inf%
14.60
US$24,995 		1,712 +inf% 14.60 US$24,995
2022-08-15 2022-08-11 B Purchase
2.3
ELSON CHARLES M
Non-Executive Director
3,700 +20.1%
13.55
US$50,135 		3,700 +20.1% 13.55 US$50,135
2022-08-10 2022-08-09 B Purchase
2.7
Jacobsmeyer Barbara Ann

President and CEO

Executive Director
30,000 +14.4%
13.78
US$413,400 		30,000 +14.4% 13.78 US$413,400
2022-08-10 2022-08-09 B Purchase
3.2
SHAW L EDWARD JR
Non-Executive Director
10,000 +52.7%
13.64
US$136,400 		10,000 +52.7% 13.64 US$136,400
2022-08-10 2022-08-08 B Purchase
2.4
MAUPIN JOHN E JR D D S
Non-Executive Director
1,000 +6.1%
13.59
US$13,590 		1,000 +6.1% 13.59 US$13,590
2022-08-10 2022-08-08 B Purchase
2.4
CURL YVONNE M
Non-Executive Director
1,500 +9.3%
13.75
US$20,625 		1,500 +9.3% 13.75 US$20,625
2022-08-08 2022-08-04 B Purchase
3.5
Bolton Jeffrey
Non-Executive Director
1,000 +15.2%
11.74
US$11,740 		1,000 +15.2% 11.74 US$11,740
2022-08-08 2022-08-04 B Purchase
3.4
HIGDON LEO I JR
Non-Executive Director
3,000 +66.7%
12.37
US$37,110 		3,000 +66.7% 12.37 US$37,110
2022-08-08 2022-08-04 B Purchase
1.8
LaMonica Susan
Non-Executive Director
15,000 +185.3%
11.72
US$175,800 		15,000 +185.3% 11.72 US$175,800
2022-08-05 2022-08-03 B Purchase
3.4
HIGDON LEO I JR
Non-Executive Director
4,500 +inf%
13.57
US$61,065 		4,500 +inf% 13.57 US$61,065
Explore more

More insider trading research around Enhabit Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Providers & Services companies with insider activity
Insider trading in North America